# Nasdaq's Wild Ride: Splits, Dreams, and Chaos!

Newsy: Bud Fox's 3 Controversial Stocks of the Day
Published: 2026-07-25T14:00:00.501Z
Source: https://newsyai.com/edition/03e46a4c-562e-45e2-85f8-be1a6998fa15
Archive: https://newsyai.com/newsy/bde0e0f6-7fac-4abb-93a8-996b5464e3e9.md

---

**Nasdaq’s Reverse-Split Shitshow: EV Pipe Dreams, China EV Fails & Construction Clowns – July 25, 2026 Edition!**

Futures still mixed (Dow snoring, Nasdaq riding that AI/chip high while crude oil keeps flexing like a strip-club bouncer). Yesterday’s carnage is old news; Nasdaq’s reverse-split guillotine keeps dropping with zero mercy for repeat offenders. Retail degens are foaming at the post-split pump, bears are sharpening dilution daggers. Balls-deep into three fresh volatility junkies where bulls and bears are screaming past each other louder than floor traders at close.

### 1) Faraday Future Intelligent Electric Inc. (FFAI): “1-for-150 EV/AI Wet Dream vs. Dilution Tsunami & Governance Graveyard”

**Why it’s loud**  
Massive 1-for-150 reverse split effective amid compliance desperation. EV/AI hype machine hyped as the next big thing. Bulls drool over any EV sales bounce or AI angle with the shrunken float; bears hammer chronic cash burn, endless dilution, governance nightmares, and “EV autopsy” energy.

**Bull case (compliance rocket + EV stiffy)**  
Insane ratio + volume spike + any China/EV or tech positive = $1–6+ rip. Ride the fantasy, apes—narrative rocket fuel on the tiny float!

**Bear case (dilution gangbang & split limp encore)**  
150x desperation screams ongoing capital hunger, brutal EV competition, repeated raises = sub-$0.02 graveyard. Short the fade before the next offering tsunami!

**My take, first principles (real EV signal vs. listing cancer)**  
Genuine low-float EV/AI narrative offers short-term hype juice in electric vehicles, but insane split ratio, dilution history, stricter Nasdaq rules, and microcap chaos scream unsustainable trap. Real operational moonshot with lottery vibes. Scalp the spunk? **$0.05–1.40** range, **$0.35C** EV pump—**P$0.04** dilution fade.

### 2) Trinity Biotech plc (TRIB): “1-for-30 Diabetes Diagnostics Dream vs. Cash-Burn & Execution Nightmares”

**Why it’s loud**  
1-for-30 reverse split hitting for Nasdaq $1 compliance. Diabetes diagnostics play hyped as recovery story. Bulls hype any regulatory or sales positive with post-split shrink; bears pound chronic cash burn, execution flops, and “biotech graveyard” vibes.

**Bull case (compliance rocket + diagnostics boner)**  
Big ratio + volume spike + any healthcare or test news = $1–5+ rip. Ride the recovery fantasy, degens!

**Bear case (dilution gangbang & split limp encore)**  
30x desperation screams capital needs, brutal competition in diagnostics, repeated raises = sub-$0.03 graveyard. Short the fade before the next offering tsunami!

**My take, first principles (real diagnostics signal vs. listing cancer)**  
Genuine diabetes testing niche offers short-term narrative juice in healthcare, but cash burn, dilution overhang, Nasdaq scrutiny, and microcap volatility scream trap. Real operational niche with token risk. Scalp it? **$0.07–1.80** range, **$0.42C** diagnostics pump—**P$0.05** dilution fade.

### 3) Digital Brands Group Inc. (DBGI): “1-for-40 Retail Recovery Hype vs. Chronic Dilution & Competition Fails”

**Why it’s loud**  
1-for-40 reverse split effective today amid compliance wave. E-commerce/retail apparel play hyped as comeback story. Bulls eye any sector tailwinds or hype with tiny post-split float; bears hammer extreme dilution history, weak fundamentals, and “retail wipeout” energy.

**Bull case (compliance rocket + retail boner)**  
Insane ratio + volume spike + any fashion or e-comm news = $1–4+ rip. Ride the narrative fantasy, apes!

**Bear case (dilution gangbang & split limp encore)**  
40x desperation screams ongoing capital needs, brutal retail competition, repeated raises = sub-$0.02 graveyard. Short the fade before the next offering tsunami!

**My take, first principles (real retail signal vs. listing cancer)**  
Genuine low-float e-comm appeal offers short-term hype juice, but dilution history, stricter Nasdaq rules, and microcap volatility scream unsustainable trap. Real operational moonshot with lottery vibes. Scalp the spunk? **$0.06–1.60** range, **$0.38C** retail pump—**P$0.05** dilution fade.

**Tape-Side Tactics (FFAI EV Blasts, TRIB Diagnostics Chaos & DBGI Retail Fails – July 25 Edition)**  
- **FFAI**: **$0.05–1.40** stiffy; **$0.35C** EV pump, **P$0.04** fade.  
- **TRIB**: **$0.07–1.80** stiffy; **$0.42C** diagnostics pump, **P$0.05** fade.  
- **DBGI**: **$0.06–1.60** stiffy; **$0.38C** retail pump, **P$0.05** fade.  

New split rules still tightening the noose amid crude cock-up and micro-madness. Balls-deep DYOR, NFA, degens duck the dilutions!

**Sources** (for tracking every claim above):  
- Reverse splits & reactions: Nasdaq Trader Corporate Actions Alerts, Yahoo Finance/StockTitan/GlobeNewswire announcements (July 2026 data).  
- Company announcements & details: BusinessWire, StockTitan press releases, SEC filings.  
- Nasdaq reverse-split rule changes & compliance: Federal Register, Norton Rose Fulbright analyses (2025–2026 updates).  
- Broader microcap/premarket context & volatility: Yahoo Finance, recent company filings.
